Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation ESC 2025

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Presenter: Martine Gilard

August 30, 2025

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation ESC 2016

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Presenter: Ik-Kyung Jang

August 30, 2016

Presentation ESC 2016

DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting?

Presenter: Nicolas Meneveau

August 29, 2016

Presentation ESC 2016

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Presenter: Gilles Montalescot

August 28, 2016

Presentation ESC 2012

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Presenter: William Wijns

August 27, 2012

Advertisement

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

DOCTORS: Does Optical Coherence Tomography Optimise Results of Stenting?

ANTARCTIC: Assessment of a Normal vs Tailored Dose of Prasugrel After Stenting in 75 yo Patients to Reduce the Composite of Bleeding, Stent Thrombosis and Ischemic Complications

Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content